Janet Hong

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem et al. · Annals of Oncology · 2018 · 503 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100

Markus Moehler, Mikhail Dvorkin, Narikazu Boku et al. · Journal of Clinical Oncology · 2020 · 223 citations · Full text

Medicine, Oncology, Pharmacology +15

Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial

Hyun Cheol Chung, Hendrik-Tobias Arkenau, Jeeyun Lee et al. · Journal for ImmunoTherapy of Cancer · 2019 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2− advanced gastric or gastroesophageal junction cancer (GC/GEJC).

Markus Moehler, Mikhail Dvorkin, Mustafa Özgüroğlu et al. · Journal of Clinical Oncology · 2020 · 50 citations

Medicine, Oncology, Pharmacotherapy +17

Serratus Anterior Plane Block Versus Intercostal Block with Incision Infiltration in Robotic-Assisted Thoracoscopic Surgery: A Randomized Controlled Pilot Trial

Poonam Pai, Janet Hong, A. J. PHILLIPS et al. · Journal of Cardiothoracic and Vascular Anesthesia · 2021 · 11 citations

Medicine, Surgery, Medical Robotics +10